At Janssen, we remain steadfast in our commitment to uncover novel treatment approaches and advance research for inflammatory bowel diseases (IBD) like Crohn’s disease and ulcerative colitis. Our commitment to IBD drug development spans over two decades, and our portfolio of IBD clinical trials aims to bring potential investigational medications to patients as quickly as possible through research. While we do not currently have any IBD clinical trials enrolling new participants, our commitment to pioneering research is unwavering, and we continue to explore innovative approaches that may someday change what an IBD diagnosis means for current and future generations.
New clinical trials will be added to this website as they become available. In the meantime, you can answer the brief questionnaire below and have your information saved—that way you can be notified of future IBD clinical trials. Please note that by completing the questionnaire below, you will not be enrolling in a clinical trial. Instead, you are opting to have your information saved to potentially participate in future trials as they become available.
Clinical Trial Media, our affiliates, and our service providers will use your responses to these questions to determine your potential eligibility to participate in future clinical trials for which you may be eligible, and to contact you. Our Privacy Policy further governs the use of the information that you provide.